Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Apollo Hospitals Enterprise Limited

APOLLOHOSP.NSNSE
Healthcare
Medical - Care Facilities
7775.00
-8.00(-0.10%)
Indian Market opens in 6h 37m

Apollo Hospitals Enterprise Limited Fundamental Analysis

Apollo Hospitals Enterprise Limited (APOLLOHOSP.NS) shows moderate financial fundamentals with a PE ratio of 62.10, profit margin of 7.44%, and ROE of 21.28%. The company generates $242.2B in annual revenue with strong year-over-year growth of 14.35%.

Key Strengths

ROE21.28%
Current Ratio1.64

Areas of Concern

Cash Position2.81%
PEG Ratio7.98
We analyze APOLLOHOSP.NS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 59.4/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
59.4/100

We analyze APOLLOHOSP.NS's fundamental strength across five key dimensions:

Efficiency Score

Weak

APOLLOHOSP.NS struggles to generate sufficient returns from assets.

ROA > 10%
8.21%

Valuation Score

Weak

APOLLOHOSP.NS trades at a premium to fair value.

PE < 25
62.10
PEG Ratio < 2
7.98

Growth Score

Excellent

APOLLOHOSP.NS delivers strong and consistent growth momentum.

Revenue Growth > 5%
14.35%
EPS Growth > 10%
60.90%

Financial Health Score

Excellent

APOLLOHOSP.NS maintains a strong and stable balance sheet.

Debt/Equity < 1
0.88
Current Ratio > 1
1.64

Profitability Score

Weak

APOLLOHOSP.NS struggles to sustain strong margins.

ROE > 15%
21.28%
Net Margin ≥ 15%
7.44%
Positive Free Cash Flow
No

Key Financial Metrics

Is APOLLOHOSP.NS Expensive or Cheap?

P/E Ratio

APOLLOHOSP.NS trades at 62.10 times earnings. This suggests a premium valuation.

62.10

PEG Ratio

When adjusting for growth, APOLLOHOSP.NS's PEG of 7.98 indicates potential overvaluation.

7.98

Price to Book

The market values Apollo Hospitals Enterprise Limited at 12.30 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

12.30

EV/EBITDA

Enterprise value stands at 30.24 times EBITDA. This signals the market has high growth expectations.

30.24

How Well Does APOLLOHOSP.NS Make Money?

Net Profit Margin

For every $100 in sales, Apollo Hospitals Enterprise Limited keeps $7.44 as profit after all expenses.

7.44%

Operating Margin

Core operations generate 18.10 in profit for every $100 in revenue, before interest and taxes.

18.10%

ROE

Management delivers $21.28 in profit for every $100 of shareholder equity.

21.28%

ROA

Apollo Hospitals Enterprise Limited generates $8.21 in profit for every $100 in assets, demonstrating efficient asset deployment.

8.21%

Following the Money - Real Cash Generation

Operating Cash Flow

Apollo Hospitals Enterprise Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Apollo Hospitals Enterprise Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

APOLLOHOSP.NS converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

62.10

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

7.98

vs 25 benchmark

P/B Ratio

Price to book value ratio

12.30

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.62

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.88

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.64

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.21

vs 25 benchmark

ROA

Return on assets percentage

0.08

vs 25 benchmark

ROCE

Return on capital employed

0.26

vs 25 benchmark

How APOLLOHOSP.NS Stacks Against Its Sector Peers

MetricAPOLLOHOSP.NS ValueSector AveragePerformance
P/E Ratio62.1029.45 Worse (Expensive)
ROE21.28%779.00% Weak
Net Margin7.44%-24936.00% (disorted) Weak
Debt/Equity0.880.26 Weak (High Leverage)
Current Ratio1.644.65 Neutral
ROA8.21%-19344.00% (disorted) Weak

APOLLOHOSP.NS outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Apollo Hospitals Enterprise Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

87.50%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

207.55%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

44.36%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ